Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Fagron N.V. Major Shareholding Notification 2008

Oct 7, 2008

3949_iss_2008-10-06_5fd31337-b318-4e58-b76e-8f60ecc39b87.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

6 OCTOBER 2008

Disclosure of received notifications, in accordance with the Act of 2 May 2007

________________________________________________________________________

Waregem, 6 October 2008 – In accordance with the stipulations of article 29 of the Act of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Arseus informs that it has received the following three notifications of shareholding (situation on 1 September 2008):

  • Fortis Investment Management SA 2,756,357 voting rights

Omega Pharma NV 7,500,000 voting rights Couckinvest NV / Coucke 3,858,080 voting rights

Based on these notifications and the denominator of 31,195,121 (total number of voting rights), the structure of the shareholding is as follows:

Fortis Investment Management SA 8.84%
Omega Pharma NV 24.04%
Couckinvest NV / Coucke 12.37%
Public 54.75%

The original notification forms are also available on the corporate website (www.arseus.com).

This is a translation of the Dutch press release; the Dutch press release prevails.

For further information: Constantijn van Rietschoten, Investor Relations Manager +31 6 536 91 585 (mobile) [email protected]